Hyperlipoproteinemia Type III
What is Hyperlipoproteinemia Type III?
Hyperlipoproteinemia type III is a rare genetic condition that causes abnormal levels of fats in your blood. This disorder is also called dysbetalipoproteinemia or remnant removal disease. It happens when your body cannot properly clear certain fat particles from your bloodstream.
The condition is almost always linked to inheriting two copies of the ApoE2 gene variant. This genetic pattern affects how your liver processes triglycerides and cholesterol. Fat particles called remnants build up in your blood instead of being broken down normally. These remnants contain both cholesterol and triglycerides in roughly equal amounts.
Most people with two ApoE2 genes never develop symptoms. Only about 10 percent of people with this genetic makeup actually develop hyperlipoproteinemia type III. Additional factors like diabetes, obesity, or hypothyroidism usually trigger the condition. Early detection through genetic testing helps you prevent serious complications before they start.
Symptoms
- Yellow-orange deposits on your palms and fingers, called palmar xanthomas
- Yellow bumps on your elbows, knees, or buttocks, called tuberous xanthomas
- Fatty deposits around your eyes, called xanthelasmas
- Early heart disease, often before age 50
- Peripheral artery disease affecting legs and feet
- Chest pain or angina from reduced blood flow
- Leg pain when walking due to poor circulation
- Pancreatitis with severe abdominal pain
Many people show no symptoms in the early stages. The condition often goes unnoticed until cholesterol deposits become visible or cardiovascular problems develop. Regular blood testing can catch this disorder before symptoms appear.
Concerned about Hyperlipoproteinemia Type III? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Hyperlipoproteinemia type III requires two main factors to develop. First, you must inherit two copies of the ApoE2 gene variant, one from each parent. This genetic pattern occurs in about 1 to 2 percent of the general population. Second, you need an additional trigger that disrupts your fat metabolism further. These triggers include diabetes, hypothyroidism, obesity, kidney disease, or excessive alcohol use.
Other risk factors can worsen the condition or make it appear earlier in life. A diet high in saturated fats and refined carbohydrates adds extra burden to your lipid processing. Certain medications like estrogen therapy or beta blockers can trigger symptoms in genetically susceptible people. Men typically develop symptoms in their 20s to 40s, while women often show signs after menopause. The condition is extremely rare without the double ApoE2 genotype.
How it's diagnosed
Doctors diagnose hyperlipoproteinemia type III through a combination of blood tests and genetic analysis. Standard lipid panels show elevated cholesterol and triglyceride levels that are roughly equal, which is unusual. A more specific test measures your ApoE genotype to confirm whether you carry two copies of the ApoE2 variant. Rite Aid offers ApoE genotype testing as an add-on to help identify your genetic risk for this condition.
Your doctor may also order additional tests to measure lipid particle sizes and remnant cholesterol levels directly. Blood samples are typically collected after fasting for 9 to 12 hours for accurate results. The distinctive lipid pattern combined with ApoE2/E2 genotype confirms the diagnosis. Your doctor will also screen for secondary triggers like thyroid problems or diabetes that may need separate treatment.
Treatment options
- Follow a low-fat diet with less than 30 percent of calories from fat
- Reduce saturated fat intake and avoid trans fats completely
- Limit refined carbohydrates and added sugars
- Increase fiber intake through vegetables, legumes, and whole grains
- Maintain a healthy weight through portion control and regular activity
- Exercise for at least 30 minutes most days of the week
- Avoid alcohol entirely, as it worsens triglyceride levels
- Take statin medications like atorvastatin or rosuvastatin as prescribed
- Use fibrate medications such as fenofibrate to lower triglycerides
- Treat underlying conditions like diabetes or hypothyroidism promptly
- Work with a lipid specialist for difficult cases
- Monitor lipid levels every 3 to 6 months after starting treatment
Need testing for Hyperlipoproteinemia Type III? Add it to your panel.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
This condition causes roughly equal elevations in both cholesterol and triglycerides, which is unusual. Most other lipid disorders show one type of fat being much higher than the other. The condition also requires a specific genetic pattern, the ApoE2/E2 genotype, to develop. Distinctive yellow-orange fat deposits on the palms are another unique feature rarely seen in other conditions.
This condition affects about 1 in 10,000 people in the general population. While 1 to 2 percent of people carry two ApoE2 genes, only about 10 percent of them develop the actual disorder. The condition requires both the genetic predisposition and additional metabolic triggers to become active. It remains one of the less common inherited lipid disorders.
Yes, many people with this condition have no obvious symptoms in the early stages. You might not notice problems until cholesterol deposits appear on your skin or heart disease develops. Blood tests can detect the abnormal lipid patterns before complications occur. This is why genetic testing and regular screening are valuable for people with family history of early heart disease.
The ApoE genotype test identifies which versions of the APOE gene you inherited from your parents. This test specifically looks for the E2, E3, and E4 variants of the gene. Having two E2 copies is the primary genetic requirement for developing hyperlipoproteinemia type III. The test helps confirm diagnosis and identify family members who may be at risk.
Yes, diet changes are extremely effective even though the condition has genetic roots. Reducing saturated fat and refined carbohydrates can significantly lower your lipid levels. Many people see dramatic improvement with dietary changes alone, though most also need medication. The genetic component makes you susceptible, but lifestyle factors often determine whether symptoms actually develop.
Palmar xanthomas are yellow-orange fatty deposits that appear in the creases of your palms and fingers. They are a distinctive sign of hyperlipoproteinemia type III and rarely occur in other conditions. While they are not dangerous themselves, they signal very high lipid levels that increase your heart disease risk. See a doctor promptly if you notice these deposits developing.
Most people see significant improvement within 4 to 8 weeks of starting treatment. Combining diet changes with medication typically produces the fastest results. Your doctor will recheck your lipid levels after 6 to 12 weeks to assess treatment effectiveness. Some people achieve normal or near-normal levels, while others need ongoing medication adjustments.
Yes, first-degree relatives like siblings and children should consider ApoE genotype testing. Each sibling has a 25 percent chance of also carrying two ApoE2 genes if both parents are carriers. Children will inherit at least one ApoE2 gene from you, and their risk depends on the other parent's genotype. Early identification helps family members take preventive steps before complications develop.
Yes, very high triglyceride levels from this condition can trigger acute pancreatitis. This happens when triglycerides exceed 1,000 mg/dL, though not everyone at this level develops pancreatitis. Symptoms include severe upper abdominal pain, nausea, and vomiting that require immediate medical attention. Controlling your lipid levels through treatment greatly reduces this risk.
Yes, the genetic predisposition is permanent and requires ongoing management. However, many people maintain normal or near-normal lipid levels with consistent treatment and lifestyle changes. Your management plan may need adjustments over time as other health factors change. Regular monitoring and working closely with your doctor help you stay healthy and prevent complications long-term.